Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China

Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinat...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Li Xue [verfasserIn] Wenqi Hu [verfasserIn] Haiman Zhang [verfasserIn] Zhongling Xie [verfasserIn] Xi Zhang [verfasserIn] Fanghui Zhao [verfasserIn] Youlin Qiao [verfasserIn] Lijie Gao [verfasserIn] Wei Ma [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2018

Schlagwörter:	human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education

Übergeordnetes Werk:	In: Human Vaccines & Immunotherapeutics - Taylor & Francis Group, 2022, 14(2018), 2, Seite 404-411
Übergeordnetes Werk:	volume:14 ; year:2018 ; number:2 ; pages:404-411

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.1080/21645515.2017.1393132

Katalog-ID:	DOAJ096591374

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ096591374
003	DE-627
005	20240413153550.0
007	cr uuu---uuuuu
008	240413s2018 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1080/21645515.2017.1393132 \|2 doi
035			\|a (DE-627)DOAJ096591374
035			\|a (DE-599)DOAJ0548f6946ea1445582a437f672ec5856
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC581-607
050		0	\|a RM1-950
100	0		\|a Li Xue \|e verfasserin \|4 aut
245	1	0	\|a Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China
264		1	\|c 2018
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine.
650		4	\|a human papillomavirus (hpv)
650		4	\|a willingness to be vaccinated
650		4	\|a middle school students
650		4	\|a vaccine
650		4	\|a sex education
653		0	\|a Immunologic diseases. Allergy
653		0	\|a Therapeutics. Pharmacology
700	0		\|a Wenqi Hu \|e verfasserin \|4 aut
700	0		\|a Haiman Zhang \|e verfasserin \|4 aut
700	0		\|a Zhongling Xie \|e verfasserin \|4 aut
700	0		\|a Xi Zhang \|e verfasserin \|4 aut
700	0		\|a Fanghui Zhao \|e verfasserin \|4 aut
700	0		\|a Youlin Qiao \|e verfasserin \|4 aut
700	0		\|a Lijie Gao \|e verfasserin \|4 aut
700	0		\|a Wei Ma \|e verfasserin \|4 aut
773	0	8	\|i In \|t Human Vaccines & Immunotherapeutics \|d Taylor & Francis Group, 2022 \|g 14(2018), 2, Seite 404-411 \|w (DE-627)718665929 \|w (DE-600)2664177-X \|x 2164554X \|7 nnns
773	1	8	\|g volume:14 \|g year:2018 \|g number:2 \|g pages:404-411
856	4	0	\|u https://doi.org/10.1080/21645515.2017.1393132 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/0548f6946ea1445582a437f672ec5856 \|z kostenfrei
856	4	0	\|u http://dx.doi.org/10.1080/21645515.2017.1393132 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2164-5515 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2164-554X \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 14 \|j 2018 \|e 2 \|h 404-411

Indexfelder

author_variant	l x lx w h wh h z hz z x zx x z xz f z fz y q yq l g lg w m wm
matchkey_str	article:2164554X:2018----::wrnsoadilnnstbvciaebhmnailmvrsacnaoguiri
hierarchy_sort_str	2018
callnumber-subject-code	RC
publishDate	2018
allfields	10.1080/21645515.2017.1393132 doi (DE-627)DOAJ096591374 (DE-599)DOAJ0548f6946ea1445582a437f672ec5856 DE-627 ger DE-627 rakwb eng RC581-607 RM1-950 Li Xue verfasserin aut Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine. human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education Immunologic diseases. Allergy Therapeutics. Pharmacology Wenqi Hu verfasserin aut Haiman Zhang verfasserin aut Zhongling Xie verfasserin aut Xi Zhang verfasserin aut Fanghui Zhao verfasserin aut Youlin Qiao verfasserin aut Lijie Gao verfasserin aut Wei Ma verfasserin aut In Human Vaccines & Immunotherapeutics Taylor & Francis Group, 2022 14(2018), 2, Seite 404-411 (DE-627)718665929 (DE-600)2664177-X 2164554X nnns volume:14 year:2018 number:2 pages:404-411 https://doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/article/0548f6946ea1445582a437f672ec5856 kostenfrei http://dx.doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/toc/2164-5515 Journal toc kostenfrei https://doaj.org/toc/2164-554X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2014 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2018 2 404-411
spelling	10.1080/21645515.2017.1393132 doi (DE-627)DOAJ096591374 (DE-599)DOAJ0548f6946ea1445582a437f672ec5856 DE-627 ger DE-627 rakwb eng RC581-607 RM1-950 Li Xue verfasserin aut Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine. human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education Immunologic diseases. Allergy Therapeutics. Pharmacology Wenqi Hu verfasserin aut Haiman Zhang verfasserin aut Zhongling Xie verfasserin aut Xi Zhang verfasserin aut Fanghui Zhao verfasserin aut Youlin Qiao verfasserin aut Lijie Gao verfasserin aut Wei Ma verfasserin aut In Human Vaccines & Immunotherapeutics Taylor & Francis Group, 2022 14(2018), 2, Seite 404-411 (DE-627)718665929 (DE-600)2664177-X 2164554X nnns volume:14 year:2018 number:2 pages:404-411 https://doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/article/0548f6946ea1445582a437f672ec5856 kostenfrei http://dx.doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/toc/2164-5515 Journal toc kostenfrei https://doaj.org/toc/2164-554X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2014 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2018 2 404-411
allfields_unstemmed	10.1080/21645515.2017.1393132 doi (DE-627)DOAJ096591374 (DE-599)DOAJ0548f6946ea1445582a437f672ec5856 DE-627 ger DE-627 rakwb eng RC581-607 RM1-950 Li Xue verfasserin aut Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine. human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education Immunologic diseases. Allergy Therapeutics. Pharmacology Wenqi Hu verfasserin aut Haiman Zhang verfasserin aut Zhongling Xie verfasserin aut Xi Zhang verfasserin aut Fanghui Zhao verfasserin aut Youlin Qiao verfasserin aut Lijie Gao verfasserin aut Wei Ma verfasserin aut In Human Vaccines & Immunotherapeutics Taylor & Francis Group, 2022 14(2018), 2, Seite 404-411 (DE-627)718665929 (DE-600)2664177-X 2164554X nnns volume:14 year:2018 number:2 pages:404-411 https://doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/article/0548f6946ea1445582a437f672ec5856 kostenfrei http://dx.doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/toc/2164-5515 Journal toc kostenfrei https://doaj.org/toc/2164-554X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2014 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2018 2 404-411
allfieldsGer	10.1080/21645515.2017.1393132 doi (DE-627)DOAJ096591374 (DE-599)DOAJ0548f6946ea1445582a437f672ec5856 DE-627 ger DE-627 rakwb eng RC581-607 RM1-950 Li Xue verfasserin aut Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine. human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education Immunologic diseases. Allergy Therapeutics. Pharmacology Wenqi Hu verfasserin aut Haiman Zhang verfasserin aut Zhongling Xie verfasserin aut Xi Zhang verfasserin aut Fanghui Zhao verfasserin aut Youlin Qiao verfasserin aut Lijie Gao verfasserin aut Wei Ma verfasserin aut In Human Vaccines & Immunotherapeutics Taylor & Francis Group, 2022 14(2018), 2, Seite 404-411 (DE-627)718665929 (DE-600)2664177-X 2164554X nnns volume:14 year:2018 number:2 pages:404-411 https://doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/article/0548f6946ea1445582a437f672ec5856 kostenfrei http://dx.doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/toc/2164-5515 Journal toc kostenfrei https://doaj.org/toc/2164-554X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2014 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2018 2 404-411
allfieldsSound	10.1080/21645515.2017.1393132 doi (DE-627)DOAJ096591374 (DE-599)DOAJ0548f6946ea1445582a437f672ec5856 DE-627 ger DE-627 rakwb eng RC581-607 RM1-950 Li Xue verfasserin aut Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine. human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education Immunologic diseases. Allergy Therapeutics. Pharmacology Wenqi Hu verfasserin aut Haiman Zhang verfasserin aut Zhongling Xie verfasserin aut Xi Zhang verfasserin aut Fanghui Zhao verfasserin aut Youlin Qiao verfasserin aut Lijie Gao verfasserin aut Wei Ma verfasserin aut In Human Vaccines & Immunotherapeutics Taylor & Francis Group, 2022 14(2018), 2, Seite 404-411 (DE-627)718665929 (DE-600)2664177-X 2164554X nnns volume:14 year:2018 number:2 pages:404-411 https://doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/article/0548f6946ea1445582a437f672ec5856 kostenfrei http://dx.doi.org/10.1080/21645515.2017.1393132 kostenfrei https://doaj.org/toc/2164-5515 Journal toc kostenfrei https://doaj.org/toc/2164-554X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2014 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2018 2 404-411
language	English
source	In Human Vaccines & Immunotherapeutics 14(2018), 2, Seite 404-411 volume:14 year:2018 number:2 pages:404-411
sourceStr	In Human Vaccines & Immunotherapeutics 14(2018), 2, Seite 404-411 volume:14 year:2018 number:2 pages:404-411
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education Immunologic diseases. Allergy Therapeutics. Pharmacology
isfreeaccess_bool	true
container_title	Human Vaccines & Immunotherapeutics
authorswithroles_txt_mv	Li Xue @@aut@@ Wenqi Hu @@aut@@ Haiman Zhang @@aut@@ Zhongling Xie @@aut@@ Xi Zhang @@aut@@ Fanghui Zhao @@aut@@ Youlin Qiao @@aut@@ Lijie Gao @@aut@@ Wei Ma @@aut@@
publishDateDaySort_date	2018-01-01T00:00:00Z
hierarchy_top_id	718665929
id	DOAJ096591374
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ096591374</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413153550.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2018 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1080/21645515.2017.1393132</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ096591374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0548f6946ea1445582a437f672ec5856</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-607</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Li Xue</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">human papillomavirus (hpv)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">willingness to be vaccinated</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">middle school students</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sex education</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Immunologic diseases. Allergy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wenqi Hu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Haiman Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhongling Xie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xi Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fanghui Zhao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Youlin Qiao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lijie Gao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wei Ma</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Human Vaccines & Immunotherapeutics</subfield><subfield code="d">Taylor & Francis Group, 2022</subfield><subfield code="g">14(2018), 2, Seite 404-411</subfield><subfield code="w">(DE-627)718665929</subfield><subfield code="w">(DE-600)2664177-X</subfield><subfield code="x">2164554X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:404-411</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1080/21645515.2017.1393132</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0548f6946ea1445582a437f672ec5856</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1080/21645515.2017.1393132</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2164-5515</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2164-554X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">404-411</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Li Xue
spellingShingle	Li Xue misc RC581-607 misc RM1-950 misc human papillomavirus (hpv) misc willingness to be vaccinated misc middle school students misc vaccine misc sex education misc Immunologic diseases. Allergy misc Therapeutics. Pharmacology Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China
authorStr	Li Xue
ppnlink_with_tag_str_mv	@@773@@(DE-627)718665929
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC581-607
illustrated	Not Illustrated
issn	2164554X
topic_title	RC581-607 RM1-950 Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China human papillomavirus (hpv) willingness to be vaccinated middle school students vaccine sex education
topic	misc RC581-607 misc RM1-950 misc human papillomavirus (hpv) misc willingness to be vaccinated misc middle school students misc vaccine misc sex education misc Immunologic diseases. Allergy misc Therapeutics. Pharmacology
topic_unstemmed	misc RC581-607 misc RM1-950 misc human papillomavirus (hpv) misc willingness to be vaccinated misc middle school students misc vaccine misc sex education misc Immunologic diseases. Allergy misc Therapeutics. Pharmacology
topic_browse	misc RC581-607 misc RM1-950 misc human papillomavirus (hpv) misc willingness to be vaccinated misc middle school students misc vaccine misc sex education misc Immunologic diseases. Allergy misc Therapeutics. Pharmacology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Human Vaccines & Immunotherapeutics
hierarchy_parent_id	718665929
hierarchy_top_title	Human Vaccines & Immunotherapeutics
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)718665929 (DE-600)2664177-X
title	Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China
ctrlnum	(DE-627)DOAJ096591374 (DE-599)DOAJ0548f6946ea1445582a437f672ec5856
title_full	Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China
author_sort	Li Xue
journal	Human Vaccines & Immunotherapeutics
journalStr	Human Vaccines & Immunotherapeutics
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2018
contenttype_str_mv	txt
container_start_page	404
author_browse	Li Xue Wenqi Hu Haiman Zhang Zhongling Xie Xi Zhang Fanghui Zhao Youlin Qiao Lijie Gao Wei Ma
container_volume	14
class	RC581-607 RM1-950
format_se	Elektronische Aufsätze
author-letter	Li Xue
doi_str_mv	10.1080/21645515.2017.1393132
author2-role	verfasserin
title_sort	awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in jinan, china
callnumber	RC581-607
title_auth	Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China
abstract	Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine.
abstractGer	Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine.
abstract_unstemmed	Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2014 GBV_ILN_2190 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	2
title_short	Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China
url	https://doi.org/10.1080/21645515.2017.1393132 https://doaj.org/article/0548f6946ea1445582a437f672ec5856 http://dx.doi.org/10.1080/21645515.2017.1393132 https://doaj.org/toc/2164-5515 https://doaj.org/toc/2164-554X
remote_bool	true
author2	Wenqi Hu Haiman Zhang Zhongling Xie Xi Zhang Fanghui Zhao Youlin Qiao Lijie Gao Wei Ma
author2Str	Wenqi Hu Haiman Zhang Zhongling Xie Xi Zhang Fanghui Zhao Youlin Qiao Lijie Gao Wei Ma
ppnlink	718665929
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1080/21645515.2017.1393132
callnumber-a	RC581-607
up_date	2024-07-03T21:01:55.303Z
_version_	1803593203375407104
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ096591374</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413153550.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2018 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1080/21645515.2017.1393132</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ096591374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ0548f6946ea1445582a437f672ec5856</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-607</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Li Xue</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Willingness to be vaccinated with human papillomavirus (HPV) vaccine among junior middle school students in China is not well understood. We conducted a cross-sectional study to assess awareness of HPV and the HPV vaccine and explore the factors associated with willingness to be vaccinated. Methods: First-year students from two junior middle schools in Jinan, China were selected by cluster sampling on December 28, 2015, December 26, 2016, and January 11, 2017, and a self-administered questionnaire was used to collect information. Multivariate logistic regression was conducted to explore the factors associated with willingness to be vaccinated with the HPV vaccine. Results: A total of 1021 junior middle school students participated in this survey. Only 15.5% of them had heard of HPV and 18.9% of them had heard of the HPV vaccine. Students who were willing to take the HPV vaccine in the future accounted for 66.9%. Factors associated with the HPV vaccination were: urban junior middle school students (AOR: 1.51, 95% CI: 1.09–2.09), female students (AOR: 1.90, 95% CI: 1.36–2.66), students surveyed in 2015 (AOR: 1.69, 95% CI: 1.26–2.28), regarding menstruation/spermatorrhoea as a normal physiological phenomenon (AOR: 1.64, 95% CI: 1.14–2.36), believing vaccination is an important way to prevent diseases (AOR: 1.36, 95% CI: 1.01–1.83), believing that the first vaccination should be in infancy (AOR: 1.41, 95% CI: 1.04–1.92), believing that cervical cancer is a concern for themselves (AOR: 1.95, 95% CI: 1.28–2.97), and having heard of HPV (AOR: 1.84, 95% CI: 1.13–2.98). Conclusions: Awareness of HPV and the HPV vaccine among junior students was low, however willingness to be vaccinated was high. Education focusing on HPV-related knowledge in addition to sex education is needed to promote the coverage of the HPV vaccine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">human papillomavirus (hpv)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">willingness to be vaccinated</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">middle school students</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sex education</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Immunologic diseases. Allergy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wenqi Hu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Haiman Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zhongling Xie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xi Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fanghui Zhao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Youlin Qiao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lijie Gao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wei Ma</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Human Vaccines & Immunotherapeutics</subfield><subfield code="d">Taylor & Francis Group, 2022</subfield><subfield code="g">14(2018), 2, Seite 404-411</subfield><subfield code="w">(DE-627)718665929</subfield><subfield code="w">(DE-600)2664177-X</subfield><subfield code="x">2164554X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:404-411</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1080/21645515.2017.1393132</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/0548f6946ea1445582a437f672ec5856</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1080/21645515.2017.1393132</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2164-5515</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2164-554X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">404-411</subfield></datafield></record></collection>
score	7.400401

Nicht das Richtige dabei?

Schreiben Sie uns!

Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?